26.10.2020 | Letter to the Editor
Reply to Cengiz Beyan and Esin Beyan. Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol 97(2), 3–4, 2020
verfasst von:
Wataru Fukuokaya, Takahiro Kimura, Fumihiko Urabe, Shoji Kimura, Kojiro Tashiro, Shunsuke Tsuzuki, Yusuke Koike, Hiroshi Sasaki, Kenta Miki, Shin Egawa
Erschienen in:
International Journal of Clinical Oncology
|
Ausgabe 12/2020
Einloggen, um Zugang zu erhalten
Excerpt
We have read with great interest the letter to the editor by Esin regarding our manuscript on the value of pretreatment mean platelet volume (MPV) as a treatment-specific prognostic factor for patients with metastatic castration-resistant prostate cancer (mCRPC) [
1,
2]. The authors pointed out that the conclusion on the value of MPV was extremely optimistic because of several methodological issues regarding the measurement of MPV. …